Literature DB >> 29934561

Opioid receptors: drivers to addiction?

Emmanuel Darcq1, Brigitte Lina Kieffer2,3.   

Abstract

Drug addiction is a worldwide societal problem and public health burden, and results from recreational drug use that develops into a complex brain disorder. The opioid system, one of the first discovered neuropeptide systems in the history of neuroscience, is central to addiction. Recently, opioid receptors have been propelled back on stage by the rising opioid epidemics, revolutions in G protein-coupled receptor research and fascinating developments in basic neuroscience. This Review discusses rapidly advancing research into the role of opioid receptors in addiction, and addresses the key questions of whether we can kill pain without addiction using mu-opioid-receptor-targeting opiates, how mu- and kappa-opioid receptors operate within the neurocircuitry of addiction and whether we can bridge human and animal opioid research in the field of drug abuse.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29934561     DOI: 10.1038/s41583-018-0028-x

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  79 in total

1.  Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.

Authors:  Caroline A Arout; Andrew J Waters; R Ross MacLean; Peggy Compton; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2018-12-18       Impact factor: 4.530

Review 2.  The Opioid Crisis and the Future of Addiction and Pain Therapeutics.

Authors:  Nathan P Coussens; G Sitta Sittampalam; Samantha G Jonson; Matthew D Hall; Heather E Gorby; Amir P Tamiz; Owen B McManus; Christian C Felder; Kurt Rasmussen
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

3.  Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour.

Authors:  Ariana C Brice-Tutt; Lisa L Wilson; Shainnel O Eans; Heather M Stacy; Chloe A Simons; Grant G Simpson; Jeremy S Coleman; Michael J Ferracane; Jane V Aldrich; Jay P McLaughlin
Journal:  Br J Pharmacol       Date:  2020-07-16       Impact factor: 8.739

4.  Oxycodone-Mediated Activation of the Mu Opioid Receptor Reduces Whole Brain Functional Connectivity in Mice.

Authors:  Md Taufiq Nasseef; Jai Puneet Singh; Aliza T Ehrlich; Michael McNicholas; Da Woon Park; Weiya Ma; Praveen Kulkarni; Brigitte L Kieffer; Emmanuel Darcq
Journal:  ACS Pharmacol Transl Sci       Date:  2019-06-28

Review 5.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

6.  The orphan receptor GPR139 signals via Gq/11 to oppose opioid effects.

Authors:  Hannah M Stoveken; Stefano Zucca; Ikuo Masuho; Brock Grill; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

Review 7.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

Review 8.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

9.  Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.

Authors:  Abdelfattah Faouzi; Rajendra Uprety; Ivone Gomes; Nicolas Massaly; Attila I Keresztes; Valerie Le Rouzic; Achla Gupta; Tiffany Zhang; Hye Jean Yoon; Michael Ansonoff; Abdullah Allaoa; Ying Xian Pan; John Pintar; Jose A Morón; John M Streicher; Lakshmi A Devi; Susruta Majumdar
Journal:  J Med Chem       Date:  2020-11-10       Impact factor: 7.446

Review 10.  Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic.

Authors:  Rajiv Balyan; David Hahn; Henry Huang; Vidya Chidambaran
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-02-24       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.